What is Oruka Therapeutics, Inc.'s interest expense?

Oruka Therapeutics, Inc. (ORKA) reported interest expense of $1.47M in Q4 2024.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Oruka Therapeutics, Inc. ORKA Interest Expense

Discontinued — last reported Q4 '24

Interest Expense at other companies

Johnson & JohnsonJNJ

$272M+33.3%

Arcutis Biotherapeutics, Inc.ARQT

$4.37M+46.5%

ImmunityBio, Inc.IBRX

$13.87M+2.5%

Inhibrx Biosciences, Inc.INBX

$3.51M+30.5%

Monte Rosa Therapeutics, Inc.GLUE

$5.59M+62.6%

AmgenAMGN

——

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$4.95B+533%

Enterprise value$4.9B+690%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s interest expense?: Oruka Therapeutics, Inc. (ORKA) reported interest expense of $1.47M in Q4 2024.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.